Omega Healthcare Investors (NYSE:OHI) Updates FY 2025 Earnings Guidance

Omega Healthcare Investors (NYSE:OHI) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 2.900-2.980 for the period, compared to the consensus earnings per share estimate of 2.990. The company issued revenue guidance of -.

Omega Healthcare Investors Stock Up 1.9 %

Omega Healthcare Investors stock traded up $0.73 during mid-day trading on Wednesday, hitting $38.33. The company had a trading volume of 2,807,746 shares, compared to its average volume of 1,855,654. The company has a quick ratio of 6.48, a current ratio of 6.48 and a debt-to-equity ratio of 1.10. The stock has a market cap of $10.35 billion, a price-to-earnings ratio of 28.18, a PEG ratio of 1.08 and a beta of 0.99. The business has a fifty day moving average of $38.16 and a 200 day moving average of $39.08. Omega Healthcare Investors has a 1 year low of $27.74 and a 1 year high of $44.42.

Omega Healthcare Investors (NYSE:OHI) last issued its quarterly earnings results on Wednesday, February 5th. The real estate investment trust reported $0.74 earnings per share for the quarter, topping the consensus estimate of $0.41 by $0.33. Omega Healthcare Investors had a return on equity of 8.83% and a net margin of 34.41%. On average, sell-side analysts expect that Omega Healthcare Investors will post 2.72 earnings per share for the current fiscal year.

Omega Healthcare Investors Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, February 18th. Stockholders of record on Monday, February 10th will be given a $0.67 dividend. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.99%. The ex-dividend date is Monday, February 10th. Omega Healthcare Investors’s dividend payout ratio is currently 197.06%.

Analyst Upgrades and Downgrades

OHI has been the subject of a number of recent research reports. BNP Paribas upgraded Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price objective for the company in a research report on Thursday, October 31st. Mizuho lifted their price objective on Omega Healthcare Investors from $35.00 to $37.00 and gave the stock a “neutral” rating in a research report on Thursday, December 5th. BMO Capital Markets upgraded Omega Healthcare Investors from a “market perform” rating to an “outperform” rating and set a $45.00 price objective for the company in a research report on Monday, December 9th. Berenberg Bank initiated coverage on Omega Healthcare Investors in a research report on Friday, October 18th. They set a “buy” rating and a $45.00 price objective for the company. Finally, Royal Bank of Canada lifted their price objective on Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a “sector perform” rating in a research report on Monday, November 11th. Five research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $41.67.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.